Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastatic Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07361484
What this trial is testing

Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-Small Cell Lung Cance
BeyondSpring Pharmaceuticals Inc. 442
Large-scale testing (Phase 3)Looking for participantsNCT06881784
What this trial is testing

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Non-Small Cell Lung CancerNSCLC+2 more
Revolution Medicines, Inc. 590
Testing effectiveness (Phase 2)Looking for participantsNCT07423078
What this trial is testing

Window of Opportunity in Preserving Laryngeal Function Trial

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Locally Advanced Laryngeal Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma
Matthew Spector 87
Testing effectiveness (Phase 2)Study completedNCT03179904
What this trial is testing

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CarcinomaHER2-Positive Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8+2 more
Mayo Clinic 17
Early research (Phase 1)Ended earlyNCT04249947
What this trial is testing

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Who this might be right for
Prostatic Neoplasms, Castration-ResistantNeoplasms by Histologic TypeNeoplasms, Prostate+14 more
Poseida Therapeutics, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT04108858
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8HER2-Positive Breast CarcinomaMetastatic Breast Carcinoma
National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Study completedNCT00072852
What this trial is testing

Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine

Who this might be right for
Breast Neoplasms
Pfizer 134
Not applicableEnded earlyNCT00727532
What this trial is testing

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Hereditary Clear Cell Renal Cell CarcinomaKidney Cancer
Northwestern University 9
Early research (Phase 1)Active Not RecruitingNCT03502733
What this trial is testing

Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI) 64
Early research (Phase 1)Study completedNCT04857138
What this trial is testing

Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 80
Not applicableAvailableNCT06872489
What this trial is testing

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Who this might be right for
Neuroblastoma in ChildrenNeuroblastoma, Recurrent, RefractoryAdvanced Cancer+7 more
Second Life Therapeutics
Early research (Phase 1)Study completedNCT00030368
What this trial is testing

Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT05065710
What this trial is testing

ZL-1211 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Zai Biopharmaceutical (Suzhou) Co., Ltd. 34
Early research (Phase 1)Ended earlyNCT03871348
What this trial is testing

A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic Neoplasm
Sanofi 77
Testing effectiveness (Phase 2)Looking for participantsNCT05636215
What this trial is testing

A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 368
Early research (Phase 1)Study completedNCT00499135
What this trial is testing

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Who this might be right for
Adult Solid NeoplasmClear Cell Renal Cell CarcinomaRecurrent Renal Cell Carcinoma+2 more
National Cancer Institute (NCI) 25
Large-scale testing (Phase 3)Study completedNCT00931008
What this trial is testing

Study to Evaluate SID 530 Compared to Taxotere

Who this might be right for
Non-Small Cell Lung Cancer
SK Chemicals Co., Ltd. 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT02671435
What this trial is testing

Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

Who this might be right for
Advanced Solid Tumors
MedImmune LLC 383
Not applicableStudy completedNCT04173897
What this trial is testing

Living Better With Advanced Breast Cancer: Feasibility Evaluation of an Online Supportive Intervention.

Who this might be right for
Metastatic Breast Cancer
University of Leeds 41
Testing effectiveness (Phase 2)Looking for participantsNCT05970497
What this trial is testing

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerMelanoma Stage IIIMelanoma Stage IV+1 more
Krystal Biotech, Inc. 240
Next Page